Filed: 2/14/2024ACC: 0001937964-24-000001
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $343.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$343.73M
Total AUM (reported)
4.07M
Total Shares
Allocation by class
COM$143.49M41.7%
ADR$74.64M21.7%
PUT$57.16M16.6%
CALL$33.81M9.8%
SPONSORED ADR$25.87M7.5%
COM NEW$3.84M1.1%
SPONSORED ADS$2.60M0.8%
Portfolio Concentration
Top 3$164.50M47.9%
4–10$137.64M40.0%
11–25$39.69M11.5%
Rest$1.89M0.6%
Top 3 weight
47.9%
Top 10 weight
87.9%
Voting Authority Distribution
Total shares with voting rights: 4.07M
Sole
Full voting authority
4.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
NOVO-NORDISK A S
SOLEShares721.51K
TypeSH
Market value$74.64M
21.71%
Sole
721.51K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares92.59K
TypeSH
Market value$53.97M
15.70%
Sole
92.59K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares329.20K
TypeSH
Market value$35.89M
10.44%
Sole
329.20K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares404.90K
TypeSH
Market value$33.81M
9.83%
Sole
404.90K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares400.50K
TypeSH
Market value$33.44M
9.73%
Sole
400.50K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares40K
TypeSH
Market value$23.32M
6.78%
Sole
40K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares90.82K
TypeSH
Market value$14.07M
4.09%
Sole
90.82K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares34.24K
TypeSH
Market value$13.03M
3.79%
Sole
34.24K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$12.85M
3.74%
Sole
190.75K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares383.58K
TypeSH
Market value$7.14M
2.08%
Sole
383.58K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares87.85K
TypeSH
Market value$6.99M
2.03%
Sole
87.85K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares45K
TypeSH
Market value$5.93M
1.72%
Sole
45K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares41.60K
TypeSH
Market value$2.98M
0.87%
Sole
41.60K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares28.89K
TypeSH
Market value$2.79M
0.81%
Sole
28.89K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares32.11K
TypeSH
Market value$2.68M
0.78%
Sole
32.11K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares130.79K
TypeSH
Market value$2.60M
0.76%
Sole
130.79K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares112.34K
TypeSH
Market value$2.58M
0.75%
Sole
112.34K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares38.55K
TypeSH
Market value$2.42M
0.70%
Sole
38.55K
Shared
0.00
None
0.00
INSMED INC
SOLEShares74.94K
TypeSH
Market value$2.32M
0.68%
Sole
74.94K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares440K
TypeSH
Market value$1.96M
0.57%
Sole
440K
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$1.81M
0.53%
Sole
100K
Shared
0.00
None
0.00
CHARLES RIV LABS INTL INC
SOLEShares6.91K
TypeSH
Market value$1.63M
0.47%
Sole
6.91K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares50K
TypeSH
Market value$1.16M
0.34%
Sole
50K
Shared
0.00
None
0.00
WATERS CORP
SOLEShares2.85K
TypeSH
Market value$936.7K
0.27%
Sole
2.85K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares21.40K
TypeSH
Market value$901.5K
0.26%
Sole
21.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NOVO-NORDISK A SSOLE | ADR | 721.51K | SH | $74.64M 21.71% | 721.51K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 92.59K | SH | $53.97M 15.70% | 92.59K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 329.20K | SH | $35.89M 10.44% | 329.20K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | CALL | 404.90K | SH | $33.81M 9.83% | 404.90K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | PUT | 400.50K | SH | $33.44M 9.73% | 400.50K | 0.00 | 0.00 |
ELI LILLY & COSOLE | PUT | 40K | SH | $23.32M 6.78% | 40K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 90.82K | SH | $14.07M 4.09% | 90.82K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 34.24K | SH | $13.03M 3.79% | 34.24K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $12.85M 3.74% | 190.75K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 383.58K | SH | $7.14M 2.08% | 383.58K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 87.85K | SH | $6.99M 2.03% | 87.85K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 45K | SH | $5.93M 1.72% | 45K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 41.60K | SH | $2.98M 0.87% | 41.60K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 28.89K | SH | $2.79M 0.81% | 28.89K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 32.11K | SH | $2.68M 0.78% | 32.11K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 130.79K | SH | $2.60M 0.76% | 130.79K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 112.34K | SH | $2.58M 0.75% | 112.34K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 38.55K | SH | $2.42M 0.70% | 38.55K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 74.94K | SH | $2.32M 0.68% | 74.94K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 440K | SH | $1.96M 0.57% | 440K | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 100K | SH | $1.81M 0.53% | 100K | 0.00 | 0.00 |
CHARLES RIV LABS INTL INCSOLE | COM | 6.91K | SH | $1.63M 0.47% | 6.91K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 50K | SH | $1.16M 0.34% | 50K | 0.00 | 0.00 |
WATERS CORPSOLE | COM | 2.85K | SH | $936.7K 0.27% | 2.85K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 21.40K | SH | $901.5K 0.26% | 21.40K | 0.00 | 0.00 |
Page 1 of 2